Park Ha Biological Technology (BYAH) Accumulated Expenses (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Accumulated Expenses for 4 consecutive years, with $165964.0 the latest figure, recorded in Q2 2026.

• Quarterly Accumulated Expenses rose 10.85% year-over-year to $165964.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $165964.0 (up 10.85% YoY) and the FY2025 annual result came in at $188312.0, up 20.82% from the prior year.
• Accumulated Expenses slipped to $165964.0 in Q2 2026 per BYAH's latest filing, from $188312.0 in the prior quarter.
• Over the last five years, Accumulated Expenses for BYAH reached as high as $188312.0 in Q4 2025 and fell as low as $125156.0 in Q4 2023.
• A 4-year average of $157003.2 and a median of $155863.0 in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses increased 24.53% — and 2026, when it grew 10.85%.
• Year by year, Accumulated Expenses stood at $125156.0 in 2023, then advanced by 24.53% to $155863.0 in 2024, then grew by 20.82% to $188312.0 in 2025, then decreased by 11.87% to $165964.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $165964.0, $188312.0, and $149721.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.